Literature DB >> 7064342

Proteolytic activation of vaccinia virus for the penetration phase of infection.

Y Ichihashi, M Oie.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7064342     DOI: 10.1016/0042-6822(82)90421-4

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


× No keyword cloud information.
  8 in total

1.  The product of the vaccinia virus L5R gene is a fourth membrane protein encoded by all poxviruses that is required for cell entry and cell-cell fusion.

Authors:  Alan C Townsley; Tatiana G Senkevich; Bernard Moss
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

2.  Two distinct low-pH steps promote entry of vaccinia virus.

Authors:  Alan C Townsley; Bernard Moss
Journal:  J Virol       Date:  2007-06-06       Impact factor: 5.103

3.  A 14,000-Mr envelope protein of vaccinia virus is involved in cell fusion and forms covalently linked trimers.

Authors:  J F Rodriguez; E Paez; M Esteban
Journal:  J Virol       Date:  1987-02       Impact factor: 5.103

4.  Structural and functional studies of a 39,000-Mr immunodominant protein of vaccinia virus.

Authors:  J S Maa; M Esteban
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

5.  Electron microscopic study on vaccinia virus release.

Authors:  K Tsutsui; F Uno; K Akatsuka; S Nii
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

6.  Protease inhibitors suppress the in vitro and in vivo replication of rotavirus.

Authors:  S L Vonderfecht; R L Miskuff; S B Wee; S Sato; R R Tidwell; J D Geratz; R H Yolken
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

7.  Vaccinia virus entry into cells is dependent on a virion surface protein encoded by the A28L gene.

Authors:  Tatiana G Senkevich; Brian M Ward; Bernard Moss
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

Review 8.  The baculoviruses occlusion-derived virus: virion structure and function.

Authors:  Jeffery Slack; Basil M Arif
Journal:  Adv Virus Res       Date:  2007       Impact factor: 9.937

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.